提供学术论文选刊润色服务
医学
医学
Paper Review Records
全部论文审稿周期
10 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期；保留 PDF/DOI/网页源链接
529
天
21
天
Statistical Methodology Groups in the Pharmaceutical Industry #
作者Jenny Devenport; Tobias Mielke; Mouna Akacha; Kaspar Rufibach; Alex Ocampo; Vivian Lanius; Marc Vandemeulebroecke; Philip Hougaard; Pierre Collin; David Wright; Jurgen Hummel; Cornelia Ursula Kunz; Mike Krams
作者单位1. Hoffmann-La Roche AG; 2. Johnson and Johnson; 3. Novartis AG; 4. Merck KGaA; 5. UCB Biosciences GmbH; 6. Bayer BCC AG; 7. H. Lundbeck A/S; 8. Bristol Myers Squibb; 9. AstraZeneca UK Limited; 10. Cytel; 11. Boehringer Ingelheim International GmbH; 12. Berry Consultants
498
天
486
天
An Adaptive Biomarker-Based Umbrella Trial Design Using Bayesian Latent Class Model
作者Jiaying Guo; Mengyi Lu; Yan Han; Leng Han; Yong Zang
作者单位1. Department of Biostatistics and Health Data Sciences, School of Medicine, Indiana University; 2. Eli Lilly and Company; 3. Department of Biostatistics, Nanjing Medical University; 4. Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University
524
天
A Bayesian Adaptive Marker-Stratified Design for Phase II Clinical Trials Using Calibrated Spike-and-Slab Priors
作者Mu Shan; Mengyi Lu; Leng Han; Yan Han; Yong Zang
作者单位1. Department of Biostatistics and Health Data Sciences, School of Medicine, Indiana University; 2. Eli Lilly and Company; 3. Department of Biostatistics, School of Public Health, Nanjing Medical University; 4. Center for Computational Biology and Bioinformatics, School of Medicine, Indiana University
329
天
Statistical Method for Threshold Value Determination of Diagnostic Biomarker in Noisy Data
作者Yichen Jia; Donghui Zhang; Francois Beckers; Scott Gallichan; Elizabeth J. Kelly; Saranya Sridhar
作者单位1. Global Biostatistical Science, Sanofi Pasteur; 2. Global Immunology, Sanofi Pasteur; 3. Global Clinical Development, Sanofi Pasteur
291
天
Considerations on Interim Evaluation of OS in Pivotal Oncology Trials
作者Weidong Zhang; Sunhee Ro; Jing Zhao; Xiaoyun Li; Qi Jiang; Linda Sun; Olga Marchenko; Chengxing (Cindy) Lu; Rong Liu; on behalf of the Interim Evaluation of OS Workstream of the Statistical Methods in Oncology Scientific Working Group, Biopharmaceutical Section, American Statistical Association
作者单位1. Sana Biotechnology; 2. Nurix Therapeutics; 3. Merck & Co; 4. BeOne Medicines; 5. Pfizer Inc; 6. Bayer; 7. AstraZeneca Plc; 8. Regeneron Pharmaceuticals Inc
350
天
505
天
268
天
Expert Matching · Case Demo
把投稿要求，转成可验证的期刊方案
说清专业、时限和作者背景，CrushSCI 结合真实审稿样本，给出拟题方向、期刊初筛与周期判断。
客户询问
我是环境工程专业，需要一篇 SCI，希望 3 个月内见刊。没有基金，也没有大牛挂名，可以投哪些期刊？
CrushSCI回复
可以。先按 90 天时限做可行性筛选，同步查找无基金、无知名作者挂靠的典型论文案例，作为选刊依据。重点核对研究质量与期刊 scope。
- 拟题建议
- 《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》
样本口径2026 年最近 5 篇有效论文样本
平均审稿96.4 天
中位数77 天